Low-back pain is a worldwide-recognized problem with dramatic consequences for the quality of life of the affected people. 1,2 Epidemiological studies evidenced that all age groups, from teenagers to young and old adults, are affected by low-back pain. 2,3 In 85%-95% of the low-back patients, the diagnosis of a recognizable, specific pathology based on infection, structural deformity, or inflammatory disorder is lacking. 4 For this reason, all these patients are diagnosed with "non-specific" low-back pain. The absence of a clear and recognizable pathology results in a large variation of intervention outcomes. 5,6 Systematic reviews show that effect sizes of most treatments for non-specific low-back pain are